Myocardial Ischemia Clinical Trial
Official title:
Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI
Coronary artery disease (CAD, coronary heart disease) is the leading cause of death in the
U.S., causing 1 in 5 deaths in 2005. The current method for diagnosing coronary artery
disease that is considered most accurate is coronary angiography however it involves risk and
radiation. Alternatively nuclear imaging test and MRI stress test only permits the semi
qualitative analysis of the myocardial perfusion images.
In this proposal the investigators will develop a means to calculate Coronary Flow Reserve
(CFR) using the MRI. the investigators approach has the potential to reduce mortality from
myocardial infarction by effecting a change in the patient management paradigm. Absolute
quantification of myocardial perfusion will detect coronary stenosis and CAD in patients with
more accuracy than the semi-quantitative or qualitative analysis of perfusion images.
Measurement of Coronary Flow Reserve is important for the following reasons: decrease of
coronary flow reserve has been identified as a first effect of CAD; it provides an objective
measure of treatment efficacy.
The purpose of this study is to compare images from nuclear stress test and/or coronary
angiography with Magnetic Resonance Imaging (MRI) that will evaluate subjects with coronary
artery disease calculating myocardial blood flow using a novel MRI technique combined to an
extracellular Gadolinium-based contrast agent and stressor agent
The main hypothesis the investigators will test is that changes in myocardial blood volume,
under physiologic stress, correlate with myocardial flow reserve as measured in low spatial
resolution nuclear SPECT scans. Secondary hypothesis is that stress perfusion as quantified
with bolus height corrected gadofosveset trisodium images, better correlate with SPECT
perfusion than uncorrected, relative perfusion values.
The investigators propose implementing the scan protocol using a 1.5T or 3.0T MRI scanner.
The investigators will scan a series of 20 patients recruited from the nuclear stress lab at
Northwestern Memorial Hospital. These subjects will be approached and enrolled into a HIPPA
Compliant, IRB approved research study to assess the effectiveness of myocardial perfusion
and blood volume images to measure myocardial blood volume. Subjects will be scanned with a
modified version of the clinical stress-perfusion protocol. Correlation analysis will be used
to test the hypothesis that quantitative blood volume is an indicator of myocardial flow
reserve.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Completed |
NCT04153006 -
Comparison of Fingerstick Versus Venous Sample for Troponin I.
|
||
Completed |
NCT01205776 -
EXCEL Clinical Trial
|
N/A | |
Active, not recruiting |
NCT04555174 -
BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry
|
||
Recruiting |
NCT04582877 -
Pressure Guidewire System Multi-center, Prospective, Self-Control, Clinical Trial
|
N/A | |
Recruiting |
NCT04390672 -
Multivessel TALENT
|
N/A | |
Recruiting |
NCT03265535 -
Validation of a Single Rest-Stress Imaging Protocol for Myocardial Perfusion Imaging
|
||
Not yet recruiting |
NCT04522583 -
Increased CRP Concentrations in Patients Admitted to the Emergency Department With Troponin Elevation Aids to Rule Out Coronary Ischemia
|
||
Terminated |
NCT02407626 -
Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery
|
N/A | |
Completed |
NCT02510547 -
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
|
Phase 4 | |
Completed |
NCT02554006 -
Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings
|
N/A | |
Active, not recruiting |
NCT02189499 -
Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent
|
Phase 2 | |
Completed |
NCT02197065 -
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
|
Phase 2 | |
Completed |
NCT02264717 -
Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease
|
N/A | |
Recruiting |
NCT01681381 -
Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization
|
N/A | |
Terminated |
NCT01892917 -
BIOFLOW-III Hungary Satellite Registry
|
N/A | |
Completed |
NCT01679886 -
Comparison of Rubidium PET and SPECT With CZT Crystals for Detection of Myocardial Ischemia in Overweighed Patients and Women
|
N/A | |
Completed |
NCT02707445 -
Genotyping Influences Outcome of Coronary Artery Stenting
|
N/A | |
Completed |
NCT01434043 -
Diagnostic Accuracy of Cardiac CT Perfusion Compared to PET Imaging
|